Navigation Links
American College of Cardiology and Center of Excellence for Simulation Research of Western Michigan University (CESR) Partner for in situ Simulation to Improve Team Communication and Door-to-Balloon (D2B) Time
Date:10/20/2008

WASHINGTON, BATTLE CREEK, Mich., and EVANSTON, Ill., Oct. 20 /PRNewswire/ -- The American College of Cardiology (ACC) and the Center of Excellence for Simulation Research (CESR) of Western Michigan University announced the launch of an educational and research partnership, using in situ simulation to improve the time from hospital presentation with an acute myocardial infarction (MI) to balloon angioplasty (D2B). Mentice Inc. was selected as the exclusive technology vendor, utilizing its Vascular Intervention Simulation Trainer (VIST(TM)) and newly launched MenticeSIM(TM) platform for enhanced videocapture, skills evaluation and post-experience assessment.

The ACC is the nation's leader in promoting evidence-based care for cardiovascular disease (CVD), including its educational programs sponsored by the American College of Cardiology Foundation (ACCF) and its quality improvement efforts such as reducing door-to-balloon times through the D2B Alliance. W. Douglas Weaver, M.D., F.A.C.C., ACC President, asserted that, "I am proud that the ACC is collaborating with leaders in simulation technology to advance patient care. In situ simulation has improved safety in commercial aviation and it also will bring many benefits to acute MI care, where a team of healthcare providers must quickly and expertly respond to emergency situations where every minute counts."

"This initiative is a perfect example of using a quality improvement model as the framework for continuing education learning activities," said Elizabeth Yarboro, Senior Director of Education Strategy and Accreditation at ACC. Joseph Green, Ph.D., Chief Learning Officer, added, "Activities such as this, which are learner-centered, assess outcomes, and include measurement of discrete behavior change, will lead to quantifiable assessment of changes in competence for healthcare professionals."

William Hamman, M.D., Ph.D., cardiologist, pilot and former manager of human factors and risk assessment for United Airlines, has been a leader in adapting in situ simulation technology to healthcare models. Dr. Hamman, Director of CESR, said, "Communication among team members is a critical element to shoring up safety and improving performance. In situ simulation offers a unique opportunity for clinical and interventional cardiologists, emergency department physicians, nurses, technicians, and paramedics to identify and rectify communication and system barriers to optimal acute MI care."

"We are excited to have been selected by the ACCF/CESR partnership as the provider of endovascular simulation technology for this important project," said Tim Shannon, VP of Sales and Marketing, Mentice Inc. "Team communication, when compromised, contributes to medical errors, increased costs and additional time, which translates into lost lives and poor patient outcomes." The Mentice technology enhances the in situ experience by capturing valuable data for the researchers to evaluate during the post-simulation assessment of how each team's communication skills impacted the treatment outcome. According to Shannon, " ... the medical community will applaud the efforts of the ACCF/CESR partnership in its drive to improve patient outcomes as evidenced by this endeavor."

About the American College of Cardiology

The American College of Cardiology is leading the way to optimal cardiovascular care and disease prevention. The ACC is a 37,000-member nonprofit medical society and bestows the credential Fellow of the American College of Cardiology upon physicians who meet its stringent qualifications. The College is a leader in the formulation of health policy, standards and guidelines, and is a staunch supporter of cardiovascular research. The ACC provides professional education and operates national registries for the measurement and improvement of quality care. For more information, visit http://www.acc.org.

About CESR

The Center of Excellence for Simulation Research (CESR) is a multimillion- dollar simulation research center supported by grants from the state of Michigan's Economic Development Corporation (MEDC), and pier reviewed by the American Academy for the Advancement of Science (AAAS). Through the use of strategically designed scenarios and advanced simulation devices, (CESR) of Western Michigan University replicates real-world situations to evaluate systems, processes and team behaviors in health care organizations. Key features are the design of the simulation model, in situ simulation, and the use of video debriefing. The system uses reality-inspired scenarios of complex patient situations that require effective team coordination to achieve safe patient care (Hamman et al., 2007). While other organizations can merely observe situations that happen to occur in the health care institution, CESR can trigger situations that will force health care teams and the corresponding health care systems to function in emergent and critical scenarios without the stress of being a real patient. Website: http://psoone.org

About Mentice Inc.

Mentice is a leader in medical simulation with approximately 600 installations worldwide, 100+ validation studies and more than 30 issued and pending patents. Mentice's Family of Simulators focuses on the area of minimally invasive endovascular procedures, core skills training and assessment. Website: http://www.Mentice.com

Contacts:

American College of Cardiology

Laura Lee Hall, Ph.D.

202-375-6420

lhall@acc.org

CESR

William Hamman, M.D., Ph.D.

269-964-7850

william.hamman@wmich.edu

Mentice Inc.

Tim Shannon

1-877-MENTICE

usinfo@mentice.com


'/>"/>
SOURCE Mentice Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting
2. Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting
3. Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
4. American Heart Association Scientific Statement: Heart Patients Should Be Screened, Treated for Depression
5. American Heart Association Journal Report: Miniaturized Heart Pumps May Be Effective for Children Awaiting Transplant
6. American Heart Association Journal Report: Surgical Residents Perform Heart Surgery as Effectively as Staff Surgeons
7. International Medical Corps Matched with Top 25 American Express Members Project, Saving the Lives of Malnourished Children
8. VIA Pharmaceuticals to Present at American Heart Association Scientific Sessions 2008
9. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
10. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
11. American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 12 2016  OMS Supply, a large provider of ... announced today the recent launching of their new company ... of features that enhance the user experience and enable ... --> --> Despite ... company that started in early 2016, they have already ...
(Date:2/11/2016)... Feb. 11, 2016 - ... in Personalized Medicine and Cancer Therapy. - European ... Diagnostic Testing Markets. - Key Diagnostic Testing Markets. ... Molecular Diagnostics in Genetic Testing. - Molecular Diagnostics ... - Over-the-Counter Diagnostic Products World Markets. - ...
(Date:2/11/2016)... -- Kindred Biosciences, Inc. (NASDAQ: KIN ), a biopharmaceutical ... pets, today announced the submission to FDA of the ... (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive topline results ... the control of pyrexia (fever) in horses were recently ... --> The Chemistry, Manufacturing, and Controls technical ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... , ... Valentine’s Day is nearly upon us, and most singles could probably ... flawless hair, and a sparkling personality are all well and good, but if somebody ... home with Rover. (Actually, man’s best friend might not even want to be near ...
(Date:2/13/2016)... ... February 13, 2016 , ... In its newly ... vein visualization technology should be used to ensure patient safety when placing an ... INS Standards mandate the use of vein visualization technology in patients with difficult ...
(Date:2/12/2016)... ... 12, 2016 , ... According to an article published February 4th ... significant portion of hernia repairs throughout the United States. Commenting on this article, Beverly ... that this trend has not only been expected, but it seems to be a ...
(Date:2/12/2016)... ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future , ... , As Winston Churchill said, “Those who don’t learn from history are doomed to ... expect when they come knocking this year. But that takes time. , Take a ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., a ... closed for the ISE Southeast Awards 2016. Finalists and winners of the ISE® ... Southeast Executive Forum and Awards Gala on March 15, 2016 at the Westin ...
Breaking Medicine News(10 mins):